Zensar Technologies Ltd (ZENSARTECH) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Zensar Technologies Ltd on NSE and BSE, with an AI summary of each filing.
Q2 FY27 Earning Call Transcript
Transcript · 05 Nov 2026, 12:20 am
Audio Recording of Q2FY27 Results Earnings Call held on October 29, 2026
Audio / Video · 29 Oct 2026, 10:53 pm
Zensar Technologies Releases Audio Recording for Q2FY27 Earnings Call Zensar Technologies announced that the audio recording of its Q2FY27 earnings conference call, held on 29th Oct'26 at 08:30 AM IST to discuss financial results for the quarter ended 30th Sep'26, is now available on the company's official website. Investors and market participants can access the recording directly under the Investor Corner section.
Investor Presentation - Outcome of Board Meeting.
Investor Presentation · 29 Oct 2026, 4:04 am
Zensar Technologies Reports Q2FY27 Results With 4.1% CC Revenue Growth Zensar Technologies reported Q2FY27 revenue of $166.2M, up 4.1% QoQ in constant currency and 11.5% YoY in INR terms (₹15,852M). EBITDA reached $26.2M (₹2,497M) with margins expanding 120 bps QoQ to 15.8%, while PAT stood at $20.0M (₹1,902M). Growth was driven by BFSI (+7.1% QoQ cc) and the US region (+4.5% QoQ cc). The quarterly order book reached $151.5M (+1.5% QoQ), with AI-influenced deals accounting for 36%. Utilization rose 250 bps QoQ to 87.6%, LTM voluntary attrition moderated to 9.3%, and total cash and investments stood at $297.3M with zero debt.
Press Release - Outcome of Board Meeting.
Press Release · 29 Oct 2026, 4:00 am
Zensar Technologies Reports Q2FY27 Results With 4.1% CC Revenue Growth Zensar Technologies reported Q2FY27 revenue of $166.2M, up 4.1% QoQ in constant currency (5.1% QoQ and 11.5% YoY in INR terms to INR 15,852M). EBITDA margin expanded 120 bps QoQ to 15.8%, with EBITDA at $26.2M (INR 2,497M), while PAT stood at $20.0M (INR 1,902M). BFSI led vertical performance with 7.1% QoQ CC growth (50.3% revenue share). Order book reached $151.5M (+1.5% QoQ), with AI-influenced deals comprising 36%. Total cash and investments stood at $297.3M with zero debt as of 30th Sep'26.
Disclosure under Regulation 30 the SEBI Listing Regulations.
Others (Uncategorized) · 29 Oct 2026, 3:57 am
Zensar Technologies Board Approves Merger of Wholly Owned Subsidiary M3BI India Zensar Technologies approved the Scheme of Amalgamation of its wholly owned subsidiary, M3bi India Private Limited, with itself on 28th Oct'26. As of 30th Sep'26, M3bi India reported a net worth of INR 1,130 mn and a six-month turnover of INR 1,235 mn, compared to Zensar's standalone net worth of INR 35,315 mn and turnover of INR 15,729 mn. Since M3bi India is fully owned, existing shares will be cancelled with no cash consideration or share issuance, leaving Zensar's shareholding pattern unchanged, subject to NCLT and regulatory approvals.
Outcome of Board Meeting
Financial Result · 29 Oct 2026, 3:50 am
Zensar Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 29 Oct 2026, 3:44 am
Zensar Technologies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 15,852 (+11.5% YoY | +5.1% QoQ) ■ EBIT: 2,129 (+9.3% YoY | +10.7% QoQ) ■ EBIT Margin (%): 13.4 (-28 bps YoY | +67 bps QoQ) ■ PAT: 1,902 (+4.4% YoY | +3.5% QoQ) ■ EPS (INR): 8.28 (+4.4% YoY | +3.6% QoQ) Zensar Technologies Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Digital and Application Services ■ Revenue: 12,446 (+12.5% YoY | +6.6% QoQ) ■ EBIT: 1,936 (+3.4% YoY | +11.6% QoQ) ■ EBIT Margin (%): 15.6 (-137 bps YoY | +70 bps QoQ) Cloud Infrastructure and Security ■ Revenue: 3,406 (+8.1% YoY | -0.1% QoQ) ■ EBIT: 627 (-1.6% YoY | -10.6% QoQ) ■ EBIT Margin (%): 18.4 (-180 bps YoY | -214 bps QoQ)
Outcome of Board Meeting
Outcome · 29 Oct 2026, 3:43 am
Intimation of Environmental, Social and Governance ("ESG") Score under regulation 30 of the SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 20 Oct 2026, 12:51 am
Zensar Technologies Secures Overall ESG Rating of 76 in Leader Category NSE Sustainability Ratings and Analytics Limited assigned Zensar Technologies an overall ESG rating of 76 under the "Leader" category, based on disclosures for FY26. Received on 15th Oct'26, the independent report was prepared without company engagement using public domain data. Following Zensar's representation regarding rating parameters, the agency confirmed the original assessment on 19th Oct'26, outlining its rationale for maintaining the score across assessed ESG metrics.
Q2FY27 Results Earnings Call Scheduled on October 29, 2026
Intimation · 29 Oct 2026, 8:30 am
Zensar Technologies Limited has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 28 Oct 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 28 Oct 2026, 5:30 am
Intimation about allotment of Equity shares by Nomination and Remuneration Committee
Others (Uncategorized) · 07 Oct 2026, 9:42 pm
Zensar Technologies Allots 162,619 Equity Shares Under ESOP Scheme Zensar Technologies announced that its Nomination and Remuneration Committee approved the allotment of 162,619 fully paid-up equity shares of face value Rs. 2 each on 7th Oct'26 pursuant to the exercise of employee stock options (ESOPs). Following this allotment, the company's issued and subscribed share capital increased to Rs. 455,486,664, comprising 227,743,332 equity shares of Rs. 2 each.
Zensar Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve the Un-audited Financial ....
Intimation · 28 Oct 2026, 5:30 am
Zensar Technologies Schedules Board Meeting on 28th Oct'26 for Q2FY27 Results Zensar Technologies Limited will hold its Board of Directors meeting on 28th Oct'26 to consider, approve, and take on record the unaudited standalone and consolidated financial results along with the Limited Review Report for the quarter and half-year ended 30th Sep'26 (Q2FY27). In compliance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed from 1st Oct'26 and will reopen 48 hours post the declaration of the financial results.
Intimation under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015- Credit Rating
Others (Uncategorized) · 31 Aug 2026, 10:20 pm
Zensar Tech: ICRA Reaffirms AA+ (Stable) Credit Rating On 31 Aug'26, ICRA reaffirmed Zensar Technologies' credit rating for its Long/Short-Term Fund-Based/Non-Fund-Based facilities. The rating remains [ICRA]AA+ (Stable)/[ICRA]A1+, indicating a high degree of safety and strong creditworthiness. This reaffirmation applies to total bank limits of ₹191.00 crore, which includes facilities from banks like Citibank, HSBC, and HDFC Bank. The stable outlook suggests low expectation of a rating change in the near term, reinforcing confidence in the company's financial stability and debt-servicing capabilities.
Intimation about allotment of Equity Shares by the Nomination and Remuneration Committee
Others (Uncategorized) · 25 Aug 2026, 12:42 am
In continuation to our letter dated July 29, 2026, this is an update on merger of M3BI LLC with Zensar Technologies Inc.
Others (Uncategorized) · 14 Aug 2026, 6:46 pm
Zensar Completes Merger Filings for US Subsidiaries Zensar Technologies has completed requisite filings for the merger of its US step-down subsidiaries, Bridgeview Life Sciences LLC and M3BI LLC, into Zensar Technologies Inc., USA. The merger of M3BI LLC with Zensar Technologies Inc. will become effective from Sep 1, '26, following the completion of filings on Aug 13, '26. Filings for the Bridgeview Life Sciences merger were previously completed. Certain post-merger filings remain under process. This restructuring simplifies the US corporate structure.
Intimation of Schedule of Analyst/Institutional Investor meeting
Intimation · 10 Aug 2026, 7:08 pm
Zensar Technologies Announces Upcoming Investor Conferences in August Zensar Technologies will participate in two key investor events in Aug'26. The company is scheduled for a group meeting at the Equirus Annual India Conference on Aug 13, and will also attend the Emkay Confluence 2026 on Aug 14. Both meetings will be held in person. Zensar has stated that no unpublished price-sensitive information will be shared during these interactions. The schedule is subject to potential changes.
Intimation of Schedule of Analyst/Institutional Investor meeting
Intimation · 10 Aug 2026, 6:58 pm
Zensar Technologies Announces Participation in Upcoming Investor Conferences Zensar Technologies will participate in two upcoming investor meetings. The company is scheduled for a group meeting at the Equirus Annual India Conference 2026 on Aug 13, '26. This will be followed by participation in the Emkay Confluence 2026 – India: Full Throttle Ahead conference on Aug 14, '26. Zensar has stated that no unpublished price-sensitive information will be disclosed during these events. The schedule remains subject to change.
Intimation of Environmental, Social and Governance (''ESG'') Rating
Others (Uncategorized) · 08 Aug 2026, 7:44 pm
Zensar Technologies Receives 'Leadership' ESG Rating from Crisil Zensar Technologies has been assigned an overall ESG Score of 74 for fiscal year 2026 by Crisil ESG Ratings & Analytics. The score places the company in the "Leadership" category, reflecting strong performance on environmental, social, and governance parameters. The report, received by the company on 7th Aug'26, was independently prepared by Crisil based on publicly available data, as Zensar did not solicit the rating. This unsolicited high score positively signals the company's robust ESG framework and transparency.
Earning Call Transcript Q1 FY27
Transcript · 06 Aug 2026, 2:25 am
Voting Results and Scrutinizer''s Report for the 63rd Annual General Meeting of the Company
Annual General Meeting · 31 Jul 2026, 11:11 pm
This in continuation of our letter dated July 29, 2026, this is an update on the merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc.
Others (Uncategorized) · 31 Jul 2026, 8:18 pm
Zensar Updates on Merger of US Subsidiaries Zensar Technologies has completed the requisite filings for merging its US step-down subsidiary, Bridgeview Life Sciences LLC, with its material wholly-owned US subsidiary, Zensar Technologies Inc. The merger will be effective from Aug 1, 2026. The company received the final intimation on Jul 31, 2026. Filings for the merger of another subsidiary, M3BI LLC, with Zensar Technologies Inc. are currently in progress. This action follows the Board's in-principle approval granted on Jul 29, 2026.
Proceedings of 63rd Annual General Meeting of the Company held on July 30, 2026
Annual General Meeting · 30 Jul 2026, 10:51 pm
Audio Recording of Q1FY27 Results Earnings Call held on July 30, 2026
Audio / Video · 30 Jul 2026, 4:50 pm
Zensar Tech Makes Q1FY27 Earnings Call Recording Available Zensar Technologies has made the audio recording of its Q1FY27 earnings call available on its corporate website. The call, held on Jul 30, 2026, discussed the company's financial results for the quarter ended Jun 30, 2026. The recording can be accessed in the Investors Corner section of the company's site.